Tag Archive for: cancer milestone

T-Cell-Dendritic-Cell interaction. © Hookipa

HOOKIPA has received a US$10m milestone under its 2022 agreement with Roche to develop an arenaviral immunotherapy for KRAS-mutated cancers.